查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032651

高雪氏症市場：按類型、診斷和治療、最終用戶和地區分類（2026-2034 年）

Gaucher Disease Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球高雪氏症市場規模達19億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到31億美元，2026年至2034年的複合年成長率為5.76%。高雪氏症症患者數量的增加、積極的研發活動以及藥物的可近性是推動市場成長的主要因素。

高雪氏症，又稱溶小體儲積症，是一種罕見的遺傳性代謝紊亂疾病，會影響人體分解和儲存脂肪的能力。此病是由Glucocerebroside缺乏所引起，這種酵素負責分解一種名為Glucocerebrosidase的脂肪化合物。戈謝氏症的症狀包括脾臟和肝臟腫大、貧血、容易瘀青和出血、肺部問題、疲勞、癲癇發作和骨骼異常。診斷包括各種身體檢查、病歷、血液檢查和影像檢查等臨床檢查，以及基因檢測以檢查是否有基因突變。高雪氏症的治療方法包括藥物治療、注射治療、酵素替代療法（ERT）、骨髓移植和基材減少療法（SRT），有助於緩解症狀相關的疼痛並提高患者的生活品質。

高雪氏症市場趨勢：

目前，個體中遺傳異常盛行率的上升以及高雪氏症症患者數量的增加是全球市場成長的主要促進因素。此外，老年人口的成長（老年人更容易患上這些疾病）也增加了對高雪氏症治療的需求。同時，為高雪氏症治療提供經濟支持並降低醫療成本的醫療保險體系的實施也在不斷推進。此外，人們對高雪氏症、其症狀和診斷的認知不斷提高，以及治療方法的便利化，都對市場產生了正面影響。許多國家的政府正在投資高雪氏症的研究和發展活動，並採取措施提供人人可及的高品質醫療保健設施。結合診斷技術的顯著進步，市場前景一片光明。此外，人們對酵素替代療法（ERT）的替代方案（例如有助於抑制Glucocerebroside分解和累積的口服療法）的認知不斷提高，也促進了市場成長。這些學名藥藥，用於緩解高雪氏症引起的疼痛。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球高雪氏症市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 高雪氏症1型
  • 高雪氏症2型
  • 高雪氏症3型
  • 其他

第7章 市場區隔：依診斷及治療分類

  • 診斷
    • 主要部分
      • 身體檢查
      • 驗血
      • 影像檢查
      • 產前篩檢和產前檢測
      • 其他
  • 治療
    • 主要部分
      • 外科手術
      • 藥物
      • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 專科診所
  • 居家照護
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：促進、抑制與機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • ISU Abxis Co. Ltd.
    • Johnson & Johnson
    • Pfizer Inc.
    • Protalix Biotherapeutics
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
Product Code: SR112026A6807

The global gaucher disease market size reached USD 1.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 5.76% during 2026-2034. Increasing number of patients suffering from Gaucher disease, extensive research and development (R&D) activities, and the easy availability of drugs represent some of the key factors driving the market.

Gaucher disease, also known as lysosomal storage disorder, is a rare genetic metabolic disorder that affects the ability of the body to break down and store fats. It is caused by glucocerebrosidase deficiency, which breaks down glucocerebroside fatty chemicals in the body. It is associated with an enlarged spleen and liver, anemia, easy bruising and bleeding, lung problems, fatigue, seizures, and bone abnormalities. It is diagnosed through various physical examinations, medical history, and laboratory tests, such as blood and imaging tests, and genetic testing to confirm the presence of a mutation in the gene. Gaucher disease can be treated using medications, injections, enzyme replacement therapy (ERT), bone marrow transplantation, and substrate reduction therapy (SRT), which aid in minimizing the pain associated with the symptoms and improve the quality of life.

GAUCHER DISEASE MARKET TRENDS:

At present, the increasing prevalence of genetic abnormalities among individuals and the rising number of patients suffering from Gaucher disease represent one of the major factors bolstering the market growth around the world. Moreover, the growing aging population that is more prone to developing these medical disorders is resulting in an increasing demand for Gaucher disease treatment. In addition, there is a rise in the implementation of health insurance policies that provide financial assistance for Gaucher disease treatment and reduce medical expenses. Apart from this, the growing awareness about Gaucher disease, its symptoms, diagnosis, and the easy availability of the treatment options is influencing the market positively. Furthermore, governments of numerous countries are investing in research and development (R&D) activities to study Gaucher disease and develop new treatments. They are also undertaking measures to offer quality healthcare facilities that are accessible to all. This, coupled with significant improvements in the diagnostic technologies, is creating a positive outlook for the market. Besides this, the rising awareness about the easy availability of ERT treatment alternatives like oral therapies that help break down glucocerebroside and reduce the accumulation is contributing to the growth of the market. They generally involve generic drugs that are readily available over the counter (OTC) and by prescription for relieving pain associated with Gaucher disease.

KEY MARKET SEGMENTATION:

Type Insights:

  • Gaucher Disease Type 1
  • Gaucher Disease Type 2
  • Gaucher Disease Type 3
  • Others

Diagnosis and Treatment Insights:

  • Diagnosis
    • Physical Exam
    • Blood Tests
    • Imaging Tests
    • Preconception Screening and Prenatal Testing
    • Others
  • Treatment
    • Surgery
    • Medication
    • Others

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Homecare

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for Gaucher disease. Some of the factors driving the North America Gaucher disease market included increasing prevalence of genetic abnormalities, the presence of a well-established healthcare infrastructure, the integration of advanced medical technologies, etc.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global Gaucher disease market. Detailed profiles of all major companies have also been provided. Some of the companies covered include ISU Abxis Co. Ltd., Johnson & Johnson, Pfizer Inc., Protalix Biotherapeutics, Sanofi S.A, Takeda Pharmaceutical Company Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Gaucher Disease Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Gaucher Disease Type 1
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Gaucher Disease Type 2
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gaucher Disease Type 3
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Diagnosis and Treatment

  • 7.1 Diagnosis
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Physical Exam
      • 7.1.2.2 Blood Tests
      • 7.1.2.3 Imaging Tests
      • 7.1.2.4 Preconception Screening and Prenatal Testing
      • 7.1.2.5 Others
    • 7.1.3 Market Forecast
  • 7.2 Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Surgery
      • 7.2.2.2 Medication
      • 7.2.2.3 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Homecare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ISU Abxis Co. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Johnson & Johnson
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Pfizer Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Protalix Biotherapeutics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Sanofi S.A
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Takeda Pharmaceutical Company Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Gaucher Disease Market: Major Drivers and Challenges
  • Figure 2: Global: Gaucher Disease Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Gaucher Disease Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Gaucher Disease Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Gaucher Disease Market: Breakup by Diagnosis and Treatment (in %), 2025
  • Figure 6: Global: Gaucher Disease Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Gaucher Disease Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Gaucher Disease (Gaucher Disease Type 1) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Gaucher Disease (Gaucher Disease Type 1) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Gaucher Disease (Gaucher Disease Type 2) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Gaucher Disease (Gaucher Disease Type 2) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Gaucher Disease (Gaucher Disease Type 3) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Gaucher Disease (Gaucher Disease Type 3) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Gaucher Disease (Other Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Gaucher Disease (Other Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Gaucher Disease (Diagnosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Gaucher Disease (Diagnosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Gaucher Disease (Treatment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Gaucher Disease (Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Gaucher Disease (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Gaucher Disease (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Gaucher Disease (Specialty Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Gaucher Disease (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Gaucher Disease (Homecare) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Gaucher Disease (Homecare) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Gaucher Disease (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Gaucher Disease (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: North America: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: North America: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: United States: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: United States: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Canada: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Canada: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Asia-Pacific: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Asia-Pacific: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: China: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: China: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Japan: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Japan: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: India: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: India: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: South Korea: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: South Korea: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Australia: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Australia: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Indonesia: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Indonesia: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Others: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Others: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Europe: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Europe: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Germany: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Germany: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: France: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: France: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: United Kingdom: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: United Kingdom: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Italy: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Italy: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Spain: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Spain: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Russia: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Russia: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Others: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Others: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Latin America: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Latin America: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Brazil: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Brazil: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Mexico: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Mexico: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Middle East and Africa: Gaucher Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Middle East and Africa: Gaucher Disease Market: Breakup by Country (in %), 2025
  • Figure 76: Middle East and Africa: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Global: Gaucher Disease Industry: Drivers, Restraints, and Opportunities
  • Figure 78: Global: Gaucher Disease Industry: Value Chain Analysis
  • Figure 79: Global: Gaucher Disease Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gaucher Disease Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Gaucher Disease Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Gaucher Disease Market Forecast: Breakup by Diagnosis and Treatment (in Million USD), 2026-2034
  • Table 4: Global: Gaucher Disease Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Gaucher Disease Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Gaucher Disease Market: Competitive Structure
  • Table 7: Global: Gaucher Disease Market: Key Players